Growing evidence suggests that IQGAP3 is a biogenetic or prognostic marker of malignancy that promotes migration, invasion, and drug resistance in many human malignancies [28], such as gastric cancer [29], clear cell renal cell carcinoma [13], bladder cancer [30], and liver cancer [31]. This evidence concerns the gene IQGAP3 and clear cell renal carcinoma.